ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2004

Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees.

Anders AnellPubMed ↗Publisher ↗

No numbers read from the abstract.